Pay in 4 interest-free payments of $6.89 Learn more
Ships within 48 hours · Estimated delivery Oct 6 - Oct 11
Yuichiro Yamada at Akita University for generously donating the tagged human GLP-1R cytomegalovirus promoter vector (pCMV)
You might wonder, Is it worth it? or Will it truly work for weight loss? Fortunately, the research offers encouraging insights
Ausra et al
Most people think aging is a numbers game
Heres what it means for Medicaid enrollees: Medicaid access through the BALANCE Model could begin as early as May 2026 States must opt in voluntarily its not automatic Participating states receive federally negotiated prices from Eli Lilly (Zepbound, Mounjaro) and Novo Nordisk (Wegovy, Ozempic) Wegovy and Zepbound starting doses would cost the program $350/month (reduced from over $1,000) Patients in participating states would pay $50/month for covered GLP-1s Prior authorization and qualifying criteria will still apply This is the biggest potential expansion of GLP-1 access for Medicaid enrollees in history but it depends on your state deciding to participate
US$ 26.57
US$ 24.65
US$ 25.31
US$ 21.86
US$ 21.57
US$ 26.64
US$ 22.08
